New Advances in Chemical Research, May 2021. Catalysts allow a reaction to proceed via a pathway that has a lower activation energy than the uncatalyzed reaction.category: quinoxaline, In a article, mentioned the application of 130345-50-5, Name is Quinoxaline-6-carbaldehyde, molecular formula is C9H6N2O
The present invention relates to O-GlcNAc hydrolase (OGA) inhibitors. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which inhibition of OGA is beneficial, such as tauopathies, in particular Alzheimer’s disease or progressive supranuclear palsy; and neurodegenerative diseases accompanied by a tau pathology, in particular amyotrophic lateral sclerosis or frontotemporal lobe dementia caused by C9ORF72 mutations.
One of the oldest and most widely used commercial enzyme inhibitors is aspirin, category: quinoxaline, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 130345-50-5
Reference：
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N205 | ChemSpider